Advancing precision medicine in type 2 diabetes

Jose C Florez¹

Affiliations

Affiliation

¹ Department of Medicine and Center for Genomic Medicine, Massachusetts General Hospital, Programs in Metabolism and Medical & Population Genetics, Broad Institute Department of Medicine, Harvard Medical School, Boston, MA 02114, USA. Electronic address: jcflorez@mgh.harvard.edu.

PMID: 38142706
DOI: 10.1016/S2213-8587(23)00384-4

Comment

Advancing precision medicine in type 2 diabetes

Jose C Florez. Lancet Diabetes Endocrinol. 2024 Feb.

. 2024 Feb;12(2):87-88.

doi: 10.1016/S2213-8587(23)00384-4. Epub 2023 Dec 21.

Author

Jose C Florez¹

Affiliation

¹ Department of Medicine and Center for Genomic Medicine, Massachusetts General Hospital, Programs in Metabolism and Medical & Population Genetics, Broad Institute Department of Medicine, Harvard Medical School, Boston, MA 02114, USA. Electronic address: jcflorez@mgh.harvard.edu.

PMID: 38142706
DOI: 10.1016/S2213-8587(23)00384-4

No abstract available

PubMed Disclaimer

Conflict of interest statement

I am supported by US National Institutes of Health (NIH) grants NHLBI K24 HL157960, NIDDK U54 DK118612, NIGMS R01 GM117163, NIDDK UM1 DK126185, NIDDK R01 DK123019, and NIDDK R01 DK132299. I have received investigator-initiated grant support from Novo Nordisk, and speaker's honoraria from Novo Nordisk and Merck for research presentations over which I had full control of content. I have also received a consulting honorarium from AstraZeneca.

Comment on

Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables.
Ahlqvist E, Storm P, Käräjämäki A, Martinell M, Dorkhan M, Carlsson A, Vikman P, Prasad RB, Aly DM, Almgren P, Wessman Y, Shaat N, Spégel P, Mulder H, Lindholm E, Melander O, Hansson O, Malmqvist U, Lernmark Å, Lahti K, Forsén T, Tuomi T, Rosengren AH, Groop L. Ahlqvist E, et al. Lancet Diabetes Endocrinol. 2018 May;6(5):361-369. doi: 10.1016/S2213-8587(18)30051-2. Epub 2018 Mar 5. Lancet Diabetes Endocrinol. 2018. PMID: 29503172
Analysis of type 2 diabetes heterogeneity with a tree-like representation: insights from the prospective German Diabetes Study and the LURIC cohort.
Schön M, Prystupa K, Mori T, Zaharia OP, Bódis K, Bombrich M, Möser C, Yurchenko I, Kupriyanova Y, Strassburger K, Bobrov P, Nair ATN, Bönhof GJ, Strom A, Delgado GE, Kaya S, Guthoff R, Stefan N, Birkenfeld AL, Hauner H, Seissler J, Pfeiffer A, Blüher M, Bornstein S, Szendroedi J, Meyhöfer S, Trenkamp S, Burkart V, Schrauwen-Hinderling VB, Kleber ME, Niessner A, Herder C, Kuss O, März W, Pearson ER, Roden M, Wagner R; German Diabetes Study Group. Schön M, et al. Lancet Diabetes Endocrinol. 2024 Feb;12(2):119-131. doi: 10.1016/S2213-8587(23)00329-7. Epub 2023 Dec 21. Lancet Diabetes Endocrinol. 2024. PMID: 38142707

Publication types

Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Advancing precision medicine in type 2 diabetes

Affiliation

Advancing precision medicine in type 2 diabetes

Author

Affiliation

Conflict of interest statement

Comment on

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical